Fig. 5From: Patterns of hydroxyurea use and clinical outcomes among patients with polycythemia vera in real-world clinical practice: a chart reviewDistributions of the lowest, highest, most stable, and current HU doses with corresponding response rates. CR complete response, PR partial responseBack to article page